As per the terms of the agreement, Menarini will get the rights to Spedra in more than 40 European countries, apart from Australia and New Zealand. In exchange VIVUS will get an upfront payment of ...
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for Spedra (Vivus BV) for the treatment of erectile dysfunction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results